Pesticidal compounds from higher plants

Higher plants offer an excellent source of biologically active natural products. Over the centuries numerous plants have been exploited as sources of insecticides, but nowadays traditional botanical insecticides play only a minor role in world agriculture. Nevertheless, plant natural products still have enormous potential to inspire and influence modern agrochemical research. Few plant natural products will ever reach the market as products per se, but others will provide lead structures for programmes of synthetic chemistry and hopefully follow the success story of the synthetic pyrethroids. Structurally complex compounds, which are not amenable to synthetic chemistry programmes, may also have a role to play by validating new modes of action for pesticides. Examples are presented of compounds exhibiting insecticidal, fungicidal and herbicidal effects. Consideration is also given to the development of screening programmes to detect new compounds with interesting biological properties. Careful experimental design and thorough recording of procedures and data are crucial to success. Badly designed programmes afford only weakly active compounds or show effects which cannot be reproduced at a later date. Natural product chemistry, whether based on higher plants, micro-organisms or other sources, is a very difficult science, but there is little doubt that dedicated research will eventually be rewarded with exciting new lead structures for industrial application.     

Characterization of Pseudomonas aeruginosa isolates associated with mortality in broiler chicks

In mid-2000, a broiler chicken company in Alabama experienced high early mortality rates in chicks from two different hatcheries. Five isolates of Pseudomonas aeruginosa, obtained from these contaminated hatcheries and resulting broiler chicks with omphalitis, were selected to determine virulence of the bacteria. One-day-old specific-pathogen-free white leghorn chicks were placed into positive pressure isolation units (10 chicks per unit); feed and water were provided ad libitum. The five isolates of P. aeruginosa (1 x 10(1) or 1 x 10(1) colony-forming units/bird) were used to challenge two replicates of 10 chicks via yolk sac inoculation. Two control groups were injected with 0.1 ml of phosphate-buffered saline, and two groups received no treatment. Mortality was recorded daily, and the chicks that died were necropsied and liver and yolk sacs were cultured. After 14 days, the remaining chickens were euthanatized and necropsied. Bacterial isolates retrieved from liver and yolk sacs were identified by the API 20 NE typing system to confirm that they were the same as the challenge isolate. Virulence varied greatly among the isolates, resulting in mortality rates from 0 to 90%. The challenge isolates produced different and often distinctive postmortem lesion patterns. Antibiotic sensitivity tests showed that all five isolates were resistant to sulfisoxazole, ceftiofur, penicillin, lincomycin, bacitracin, oxytetracycline, erythromycin, naladixic acid, and tetracycline. The isolates varied in sensitivity to other antibiotics, but all isolates were sensitive to gentamicin.     

Seasonal interaction of serum vitamin D concentration and bone density in alpacas

OBJECTIVE: To evaluate temporal changes in bone mineral density associated with seasonal variation in serum vitamin D, calcium, and phosphorus concentrations in alpacas. ANIMALS: 5 healthy mature neutered male alpacas. PROCEDURE: Metacarpal bone mineral density was measured at 4 times during a year. Each time alpacas were weighed, blood was collected for determination of serum calcium, phosphorus, and vitamin D concentrations, and samples of feed were analyzed for nutrient content. Vitamin D status was determined by use of an assay that measured serum 25-hydroxycalciferol concentration. Effects of changes in serum vitamin D, calcium, and phosphorus concentration and body weight with season on bone mineral density were determined. RESULTS: Bone mineral density, body weight, and serum vitamin D and phosphorus concentrations varied with season. Bone mineral density, serum vitamin D concentration, and body weight also varied among individual alpacas. Serum vitamin D concentration was lower in January than the previous October and increased from May to the following September. The decrease in bone mineral density lagged behind the decrease in serum vitamin D concentration and was lower in May, compared with the previous October. Body weight was lower in May than the previous October or following September. Solar radiation was highest in July and lowest in December. CONCLUSIONS AND CLINICAL RELEVANCE: Seasonal changes in bone mineral density are associated with changes in serum vitamin D concentrations in alpacas. Changes in bone mineral density associated with a decline in serum vitamin D concentration may predispose some alpacas to developing fractures minimal trauma.     

Differences in metabolic parameters and gene expression related to osteochondrosis/osteoarthrosis in pigs fed 25-hydroxyvitamin D3

Osteochondrosis/osteoarthrosis (OC/OA) are common terms for various joint pathologies that occur in pigs. Pathologies that may contribute to these disorders have been described, but the primary cause(s) remain unknown. We hypothesised that as OC has some similarities to dyschondroplasia, which involves a failure of growth plate chondrocytes to fully differentiate and hypertrophy, treatment with 25-hydroxyvitamin D3 (25-D) might reduce the incidence and/or severity of lesions in pigs, as it does in chickens with dyschondroplasia. Control pigs were fed a commercial diet ad libitum. In the treated group this diet was supplemented with 25-D at 0.1 mg/kg. Ten pigs from each of the control and treated groups were sampled at 7, 12, 16 and 21 weeks. Treatment with 25-D had no effect on the incidence or severity of OC/OA lesions. Cartilage dry weight, total collagen content and proteoglycan content, and plasma levels oftotal calcium, inorganic phosphorous, vitamin C, insuline-like growth factor-I, parathyroid hormone and tumour necrosis factor alpha were unaffected by treatment. In addition, none of these parameters were correlated with the incidence or severity of OC/OA lesions. The mRNA expression levels of 21 out of 23 genes assayed by RT-PCR were unaltered in articular cartilage from OA lesion samples as compared to normal articular cartilage. However, collagen type II was reduced and collagen type X increased in OA lesion and near lesion samples. These results suggest that OA in pigs may share some features of osteoarthritis in other mammalian species.     

Clinical syndrome associated with zolpidem ingestion in dogs: 33 cases (January 1998-July 2000)

Zolpidem is a nonbenzodiazepine hypnotic of the imidazopyridine class that is used to treat insomnia in humans. Zolpidem binds selectively to the benzodiazepine omega-1 receptor and increases the frequency of chloride channel opening, which results in inhibition of neuronal excitation. A retrospective study was conducted of zolpidem ingestion in dogs that were reported to the ASPCA Animal Poison Control Center (APCC) between January 1998 and July 2000. Data analysis included amount ingested, clinical effects, and time of onset of signs. Thirty-three reports of zolpidem ingestion in dogs (ranging in age from 5 months to 16 years) were evaluated. Approximate ingested dosages ranged from 0.24 to 21 mg/kg. Clinical signs reported included ataxia (18 dogs; 54.5%), hyperactivity (10 dogs; 30.3%), vomiting (7 dogs; 21.2%), and lethargy (5 dogs; 15.2%), as well as panting, disorientation, nonspecific behavior disorder, and hypersalivation (4 dogs each sign; 12.1%). Other signs reported include tachycardia, tremors, apprehension, vocalization, hypersalivation, weakness, and hyperesthesia. In 85% percent of reports, clinical signs developed within 1 hour and usually resolved within 12 hours. Although central nervous system (CNS) depression is reported as a primary effect of zolpidem in humans and would also be expected in dogs, information obtained from this study indicates that some dogs may exhibit a paradoxical excitation reaction. This effect appears to vary among individual dogs.     

Intracranial lymphomas in simian retrovirus-positive Macaca fascicularis

Two young adult Macaca fascicularis each had unilateral mydriasis and ptosis. Both animals were euthanatized, monkey No. I for progressive neurologic signs and monkey No. 2 because of a positive intradermal tuberculin test. At necropsy, each animal had a single intracranial mass on the ventral surface of the midbrain, surrounding the oculomotor nerve. Histologically, both masses were immunoblastic lymphomas. Immunohistochemical staining revealed the neoplasms to be of B-cell origin. Simian retrovirus (SRV) was isolated from both monkeys, but simian immunodeficiency virus was not found. Both animals lacked antibody to SRV. Both animals had antibodies to Epstein-Barr-like virus (EBV), but EBV antigens were not found by immunohistochemistry. Polymerase chain reaction analysis for integrated EBV DNA was unproductive. One of the animals (monkey No. 2) had a pulmonary infection with Mycobacterium avium, suggesting that immunosuppression was present. These cases represent a unique and previously undescribed type of solitary lymphoma in SRV-infected macaques.     

Further assessment of the dietary lysine requirement of finishing gilts

A cooperative research study involving 635 gilts was conducted at eight research stations to further estimate the lysine requirement of finishing gilts. Dietary crude protein levels of the five dietary treatments ranged from 16.0 to 24.4% with calculated lysine levels of .80, .95, 1.10, 1.25, or 1.40%. Each station contributed a minimum of two replicate pens of pigs per treatment. Average initial and final weights were 53.6 and 116.4 kg, respectively. At the end of the experimental period, pigs were killed and hot carcass weight, 10th-rib fat depth, and longissimus muscle area were measured. Carcass fat-free lean percentage and fat-free lean gain were estimated from these data. Daily lysine intakes averaged 21.8, 25.9, 30.5, 34.3, and 37.8 g/d for the five treatment groups, respectively. Increasing the dietary lysine from .80 to .95% numerically increased weight gain and gain:feed, but these increases were not maintained at higher levels of dietary lysine. Overall, rate and efficiency of gain decreased (cubic, P < .01) with increasing dietary lysine. Carcasses were leaner at the two higher levels of dietary lysine as evidenced by reduced 10th rib backfat (linear, P < .01), increased longissimus area (quadratic, P < .04), and increased percentage of estimated fat-free lean (linear, P < .01). Carcass fat-free lean gain was not influenced by dietary lysine except for a small numerical improvement (P < .11) at the .95% level of dietary lysine that paralleled the improvement in body weight gain. The results indicate that the dietary lysine requirement of finishing gilts with a mean carcass fat-free lean growth rate of 306 g/d from 54 to 116 kg body weight is probably no higher than .80% of the diet to achieve maximum rate and efficiency of body weight gain and carcass lean growth rate. The results also indicate that higher dietary lysine levels may increase carcass leanness in finishing gilts, possibly due to reduced intake of NE. Whether this response is due to the effects of lysine alone, protein (i.e., other amino acids), or soybean meal is unknown.     

Variability among sources and laboratories in analyses of wheat middlings. NCR-42 Committee on Swine Nutrition

A cooperative research study was conducted by members of a regional committee (North Central Regional Committee on Swine Nutrition [NCR-42]) to assess the variability in nutrient composition (DM, CP, Ca, P, Se, NDF, and amino acids) of 14 sources of wheat middlings from 13 states (mostly in the Midwest). A second objective was to assess the analytical variability in nutrient assays among 20 laboratories (labs; 14 experiment station labs and six commercial labs). Wheat middlings were obtained from each participating station's feed mill. The bulk density of the middlings ranged from 289 to 365 g/L. The number of labs that analyzed samples were as follows: DM and CP, 20; Ca, 16; P, 15; Se, 7; NDF, 10; and amino acids, 9. Each lab used its own analytical procedures. The middlings averaged 89.6% DM, 16.2% CP, .12% Ca, .97% P, 36.9% NDF, .53 mg/kg Se, .66% lysine, .19% tryptophan, .54% threonine, .25% methionine, .34% cystine, .50% isoleucine, and .73% valine. As expected, there was considerable variation in nutrient composition among the 14 sources (P < .01), especially for Ca (.08 to .30%) and Se (.05 to 1.07 mg/kg). "Heavy" middlings (high bulk density, >335 g/L), having a greater proportion of flour attached to the bran, were lower in CP, lysine, P, and NDF than "light" middlings (<310 g/L), having cleaner bran, resulting in negative correlations between bulk density and CP (r = -.61), lysine (r = -.59), P (r = -.54), and NDF (r = -.81). Each 1-percentage-point increase in CP in the wheat middlings was associated with .0235 (r2 = .61) and 2.1 (r2 = .39)-percentage-point increases in lysine and NDF, respectively. Lysine content was associated with NDF, CP, and bulk density of wheat middlings (r2 = .88). There was considerable variation among laboratories (P < .01) in analysis of all nutrients. The CV among sources (100 x sigmaS/mean) was greater than among labs (100 x sigmaL/mean) for CP, Ca, P, Se, and NDF, but the CV among labs was greater than that among sources for DM and all of the amino acids except lysine and phenylalanine.